Richard Segal

Rich represents high-growth companies, investment banks and institutional investors in equity and debt offerings, with a focus on the technology, life sciences and consumer/retail sectors. Rich also counsels public companies on Securities and Exchange Commission compliance and reporting, and he advises private companies on a wide range of corporate and securities matters.

Since 2019, Rich has completed 120+ securities transactions, including 36 initial public offerings, that raised more than $29 billion for companies, such as:

• Akero Therapeutics*
• Alarm.com
• Apellis Pharmaceuticals*
• Appian
• argenx*
• Arteris IP*
• Avidity Biosciences*
• Cardlytics
• COMPASS Pathways*
• DigitalOcean
• Endava
• ESAB Corporation*
• Everbridge
• FuboTV*
• Karuna Therapeutics*
• Legend Biotech
• Morphic Therapeutic*
• Prelude Therapeutics*
• The Clorox Company*
• Verve Therapeutics*
• Warby Parker*

* Indicates investment bank representation

Rich’s private company client list includes DataRobot, Gopuff, Nasuni, SeatGeek, SmartAsset and Workrise.

Rich also regularly represents investment banks – including BofA Securities, Barclays Capital, BMO Capital Markets, Canaccord Genuity, Cantor Fitzgerald, Citigroup Global Markets, Cowen and Company, Credit Suisse Securities, Deutsche Bank Securities, Evercore Group, Goldman Sachs, H.C. Wainwright & Co., Jefferies, JMP Securities, J.P. Morgan Securities, Morgan Stanley, Needham & Company, Nomura Securities International, Oppenheimer & Co., Piper Sandler, Raymond James & Associates, RBC Capital Markets, Robert W. Baird & Co., Stifel, SVB Securities, UBS Securities, Wedbush Securities, Wells Fargo and William Blair & Company.